Keymed Biosciences shares rise on $320 mln windfall from Gilead-Ouro deal
Keymed Biosciences shares rise on $320 mln windfall from Gilead-Ouro dealSource: Investing.com
Keymed Biosciences shares rise on $320 mln windfall from Gilead-Ouro dealSource: Investing.com
AWS targets 2-3 gigawatts India data centre capacity, ET reportsSource: Investing.com
US stock futures fall as Iran denies talks over ending war with WashingtonSource: Investing.com
OpenAI lists Microsoft reliance as a risk in pre-IPO document- CNBCSource: Investing.com
Gilead to buy Ouro Medicines for up to $2.2 billionSource: Investing.com
Spotify cuts 15 jobs in podcasting unit restructuring - BloombergSource: Investing.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.38%Source: Investing.com
Canada stocks higher at close of trade; S&P/TSX Composite up 1.81%Source: Investing.com
How real Musk’s Terafab plans are?Source: Investing.com
U.K. stocks lower at close of trade; Investing.com United Kingdom 100 down 0.07%Source: Investing.com